Hostname: page-component-7bb8b95d7b-495rp Total loading time: 0 Render date: 2024-09-21T18:09:53.517Z Has data issue: false hasContentIssue false
  • English
  • Français

Alzheimer's Disease Clinical Trials: Where are we now?

Published online by Cambridge University Press:  02 December 2014

Jeffrey Cummings
Jeffrey Cummings*
Affiliation:
Los Angeles, California, USA
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Canadian Journal of Neurological Sciences , Volume 33 , Issue 1 , February 2006 , pp. 5
Copyright
Copyright © The Canadian Journal of Neurological 2006

References

1. Feldman, HH, Gauthier, S, Chertkow, H, et al. Canadian Guidelines for the development of antidementia therapies: A conceptual summary. Can J Neurol Sci. 2006; 33: 6–26.CrossRefGoogle ScholarPubMed